Nuclear Receptors In Age-Related Diseases: From Mechanisms To Drug Discovery

Aging Theory
Aging Pathway
Therapeutic
Nuclear receptors are key regulators in the aging process and the development of age-related diseases, presenting promising avenues for therapeutic intervention.
Author

Gemini

Published

April 13, 2026

Our bodies contain special proteins called nuclear receptors, which act like internal switches that turn genes on or off. These switches are crucial for many bodily functions, from how we develop to how our metabolism works and how our immune system responds. As we age, these nuclear receptors can sometimes malfunction, contributing to the development of common age-related conditions such as heart disease, brain disorders, and cancer. Scientists are now focusing on these receptors as potential targets for new medicines. By understanding how these “switches” work, researchers can develop drugs that either activate or block specific receptors to correct imbalances associated with aging. For example, some studies show that influencing certain nuclear receptors can improve how our bodies handle cholesterol, clean up damaged cells (a process called autophagy), or boost the energy factories within our cells (mitochondrial function). This research suggests that by carefully controlling these molecular switches, we might be able to slow down the aging process and develop effective treatments for a range of age-related diseases.


Source: link to paper